Literature DB >> 28985749

Correction to: Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21WAF1/CIP1 expression.

Dong Hwan Ho1,2, Hyejung Kim1, Jisun Kim2, Hyuna Sim3,4, Hyunjun Ahn3,4, Janghwan Kim3,4, Hyemyung Seo2, Kwang Chul Chung5, Bum-Joon Park6, Ilhong Son7,8, Wongi Seol9.   

Abstract

Entities:  

Year:  2017        PMID: 28985749      PMCID: PMC5629783          DOI: 10.1186/s13041-017-0327-6

Source DB:  PubMed          Journal:  Mol Brain        ISSN: 1756-6606            Impact factor:   4.041


× No keyword cloud information.

Correction to: Molecular brain (2015) 8:54 DOI 10.1186/s13041-015-0145-7

In the original publication of this article [1], published on 18 September 2015, it was noticed that the information on a plasmid expressing HA-tagged human p53 gene is wrong. In this Correction the incorrect and correct information on this gene are shown (and marked bold). In the first paragraph of the Methods section, the plasmid expressing HA-tagged human p53 gene is described as followed: Plasmids expressing the HA-tagged human p53 gene (16434) and FLAG-p21 (16240) were purchased from Addgene (Cambridge, MA, USA) and shLRRK2 plasmid specifically inhibiting expression of endogenous human LRRK2 (TI202451) from ORIGENE (Rockville, MD, USA). The correct description of the plasmid expressing HA-tagged human p53 gene is: Ha-p53 WT was previously described [2]. FLAG-p21 was purchased from Addgene (#16240, Cambridge, MA, USA) and shLRRK2 plasmid specifically inhibiting expression of endogenous human LRRK2 (TI202451) from ORIGENE (Rockville, MD, USA).
  2 in total

1.  NF2 blocks Snail-mediated p53 suppression in mesothelioma.

Authors:  Jung-Hyun Cho; Su-Jin Lee; Ah-Young Oh; Min-Ho Yoon; Tae-Geun Woo; Bum-Joon Park
Journal:  Oncotarget       Date:  2015-04-30

2.  Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression.

Authors:  Dong Hwan Ho; Hyejung Kim; Jisun Kim; Hyuna Sim; Hyunjun Ahn; Janghwan Kim; Hyemyung Seo; Kwang Chul Chung; Bum-Joon Park; Ilhong Son; Wongi Seol
Journal:  Mol Brain       Date:  2015-09-18       Impact factor: 4.041

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.